These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. Sanders S; Geraci SA J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876 [TBL] [Abstract][Full Text] [Related]
7. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study. Provan SA; Semb AG; Hisdal J; Stranden E; Agewall S; Dagfinrud H; Angel K; Atar D; Kvien TK Ann Rheum Dis; 2011 May; 70(5):812-7. PubMed ID: 21288959 [TBL] [Abstract][Full Text] [Related]
8. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis? Kaplan MJ Nat Clin Pract Rheumatol; 2005 Dec; 1(2):74-5. PubMed ID: 16932633 [No Abstract] [Full Text] [Related]
9. New insight into rheumatoid arthritis management. The disease and the drugs used to treat it have been linked to cardiovascular disease, melanoma, and fracture. Duke Med Health News; 2012 Feb; 18(2):1-2. PubMed ID: 22397007 [No Abstract] [Full Text] [Related]
12. Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis. Nandi P; Kingsley GH; Scott DL Curr Opin Rheumatol; 2008 May; 20(3):251-6. PubMed ID: 18388514 [TBL] [Abstract][Full Text] [Related]
13. Reducing the cardiovascular disease burden in rheumatoid arthritis. Van Doornum S; Jennings GL; Wicks IP Med J Aust; 2006 Mar; 184(6):287-90. PubMed ID: 16548834 [TBL] [Abstract][Full Text] [Related]
14. Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis. Giles JT; Post W; Blumenthal RS; Bathon JM Nat Clin Pract Rheumatol; 2006 Jun; 2(6):320-9. PubMed ID: 16932711 [TBL] [Abstract][Full Text] [Related]
15. [Determining cardiovascular risk in patients with rheumatoid arthritis: prove the efficacy of interventions first]. Thomas S Ned Tijdschr Geneeskd; 2011; 155(29):A3563. PubMed ID: 21791140 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice. Giles JT Best Pract Res Clin Rheumatol; 2015; 29(4-5):597-613. PubMed ID: 26697769 [TBL] [Abstract][Full Text] [Related]
17. [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--NSAID a possible cause?]. Pind R Ugeskr Laeger; 2011 Mar; 173(11):837; author reply 837. PubMed ID: 21520672 [No Abstract] [Full Text] [Related]
18. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752 [TBL] [Abstract][Full Text] [Related]
19. [Rheumatoid arthritis (updated Current Care guideline)]. Hakala M; Hannonen P; Helve T; Korpela M; Mattila K; Möttönen T; Varis T; Duodecim; 2009; 125(19):2131-2. PubMed ID: 19938416 [TBL] [Abstract][Full Text] [Related]
20. Developments in rheumatoid arthritis. Thomas J; Scott D Practitioner; 2006 Jun; 250(1683):31, 33, 35 passim. PubMed ID: 16856503 [No Abstract] [Full Text] [Related] [Next] [New Search]